We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Legal requirements for the sale of veterinary medicines on the internet and the VMD Accredited Internet Retailer Scheme (AIRS).
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
How to submit an application, data package and responses for proposed or existing marketing authorisations.
Information on vaccination schedules and licensed vaccines for dogs.
Benefit-Risk Submission Report (BRSR) and Pharmacovigilance Sales Submission (PSS) templates and guidance for completion of BRSRs, PSSs and signal notifications.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.
This enforcement policy sets out the general principles and approach taken by the VMD.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulati…
Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Fees charged for the specific activities carried out by the VMD.
Apply for authorisation of premises for the retail supply of POM-VPS and NFA-VPS veterinary medicines by suitably qualified persons (SQPs).
Legal requirements referred to in Schedule 1 of the Veterinary Medicines Regulations, as amended.
Register as a manufacturer, importer or distributor of active substances for use in veterinary medicines.
Guidance for the veterinary pharmaceutical industry on how to apply for and maintain a shared-label for use on veterinary medicines placed on the market in the UK and Ireland.
Information on how your personal data relating to financial transactions may be used in counter-fraud and error data matching exercises.
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).